Tag Archives: LIFO

Big Oil's Back in Washington's Taxation Crosshairs

By David Smith, The Motley Fool

Filed under:

There’s probably not another industry that even begins to match the members of Big Oil for generating antipathy in some quarters of Washington, D.C. Indeed, there are those in our nation’s capital whose clear intent it is to force the largest oil and gas producers to pay through the nose for their successes.

In his 2012 State of the Union address, President Obama stated, “The country needs an all-out, all-of-the-above strategy that develops every available source of American energy.” Fine, but that statement masked a punitive approach that the president had in mind for the bigger traditional energy companies, especially those that quest for crude oil worldwide.

Indeed, it was only a few minutes later that the president contended:

We have subsidized oil companies for a century. That’s long enough. It’s time to end the taxpayer giveaways to an industry that’s rarely been more profitable and double-down on a clean-energy industry that’s never been more promising.

The obvious implication there was that the industry has long received special favors at tax time. Which, of course, it hasn’t. Indeed, the latter statement may imply confusion between the treatment accorded to ExxonMobil and that provided to, say, Solyndra.

A targeted nailing
Nevertheless, some members of the president’s party are heeding his clarion call. In fact, Chris Van Hollen, a Democratic congressman from Maryland, is attempting to gain support for a bill that would place the industry’s companies at a clear disadvantage at tax time. His “Fair Share on High-Income Taxpayers” scheme would alter the way oil and gas operators’ taxes are calculated — especially for the larger companies — in three key ways:

  • By limiting oil and gas producers’ ability to avail themselves of the Section 199 deduction. That measure was part of the American Jobs Creation Act, which generated bipartisan support at its passage in 2004. It simply provides a 9% reduction from net income for businesses involved in the manufacturing sector. Its purpose was to serve as something of a moat to protect, at least somewhat, against foreign competition.

    Is it a measure that solely benefits energy producers? Hardly. In fact, energy companies generally have been limited to 6% deductions, while those involved in a wide range of other manufacturing endeavors receive the full 9%.

  • By limiting the industry’s use of the last-in, first-out method of valuing inventory. While a host of companies from all manner of industries have adopted what is commonly referred to as the LIFO method, Van Hollen‘s bill would render it largely off-limits to oil and gas producers.
  • By limiting the integrated companies’ deductions of royalty payments made to foreign governments. American companies operating overseas are generally permitted to deduct from their U.S. levies the taxes imposed by foreign governments — a method of preventing double taxation on their foreign income. Royalty payments made abroad have typically — and legally — been treated as taxes, making them subject to the foreign deduction. But Van Hollen‘s

    From: http://www.dailyfinance.com/2013/04/14/big-oils-back-in-washingtons-taxation-crosshairs/

AmerisourceBergen Divests Canadian Pharmaceutical Distribution Business

By Business Wirevia The Motley Fool

Filed under:

AmerisourceBergen Divests Canadian Pharmaceutical Distribution Business

VALLEY FORGE, Pa.–(BUSINESS WIRE)– AmerisourceBergen Corporation (NYS: ABC) today announced that it has signed a definitive agreement to sell its Canadian pharmaceutical distribution business, AmerisourceBergen Canada Corporation (ABCC), to Kohl & Frisch Limited, a Canadian-owned national full-line distributor. The transaction is expected to close in the third quarter of fiscal 2013, and is subject to customary closing conditions, including certain regulatory approvals. AmerisourceBergen will retain its Canadian specialty business.

The estimated sale price is expected to be between $80 million and $100 million, of which approximately half will be financed by AmerisourceBergen. As a result of the agreement, the Company expects to record an estimated loss on sale and other impairment charges of between $160 million and $180 million when it reports its quarterly results for the March quarter of fiscal 2013. This estimated loss on sale, in addition to ABCC‘s operating losses, will be reported within discontinued operations. ABCC represented approximately 2 percent of AmerisourceBergen’s total revenues.

Due to the impact of the sale, AmerisourceBergen has revised its financial performance expectations for fiscal year 2013. The Company now expects revenue growth in the range of 8 to 10 percent and it has increased its estimated earnings per share from continuing operations for fiscal 2013 from a range of $2.96 to $3.06 to a range of $3.04 to $3.14. The revised earnings per share range does not include the impact of significant one-time expenses anticipated as a result of the previously disclosed new strategic long-term relationship with Walgreen Co. and Alliance Boots, GmbH, including a LIFO expense due to an anticipated inventory build and recurring non-cash expenses relating to the equity warrants issued in connection with the new relationship. The Company continues to expect free cash flow in the range of $100 million to $200 million, and to repurchase approximately $400 million of common stock in fiscal 2013.


About AmerisourceBergen

AmerisourceBergen is one of the world’s largest pharmaceutical services companies serving the United States, Canada and selected global markets. Servicing both healthcare providers and pharmaceutical manufacturers in the pharmaceutical supply channel, the Company provides drug distribution and related services designed to reduce costs and improve patient outcomes. AmerisourceBergen’s service solutions range from niche premium logistics and pharmaceutical packaging to reimbursement and pharmaceutical consulting services. With over $80 billion in annualized revenue, …read more
Source: FULL ARTICLE at DailyFinance

International Wire Announces Fourth Quarter and Record Full Year 2012 Results

By Business Wirevia The Motley Fool

Filed under:

International Wire Announces Fourth Quarter and Record Full Year 2012 Results

CAMDEN, N.Y.–(BUSINESS WIRE)– International Wire Group Holdings, Inc. (“the Company”) (Pink Sheets: ITWG) today announced its results for the fourth quarter and full year ended December 31, 2012. Fourth quarter operating results were strong despite lower sales. Full year 2012 operating income was at a record level.

“Our strong full year operating results were driven by increased customer demand in our bare wire business, primarily from the automotive/specialty vehicles market. Demand was flat to down in our other major markets. Greater plant utilization and on-going cost reduction initiatives in our high performance conductors and European businesses as well as the favorable LIFO effects resulting from lower inventory levels also contributed to our results. We are also pleased with our debt refinancing in October of 2012 and the success of our stock tender offer,” said Rodney D. Kent, Chief Executive Officer of International Wire Group Holdings, Inc.


Fourth Quarter Results

Net sales for the quarter ended December 31, 2012 were $161.7 million, a decrease of $29.3 million, or 15.3%, compared to $191.0 million for the same period in 2011. This decrease was primarily due to a higher proportion of tolled copper (customer-owned copper, the value of which is not included in net sales and cost of sales) shipped in the 2012 period compared to the 2011 period, lower sales volume, and unfavorable currency exchange rates in Europe. These factors were partially offset by a slightly higher selling price of copper and higher customer pricing/mix. Excluding the effects of higher copper prices and a higher proportion of tolled copper, net sales decreased $9.7 million, or 5.7%, versus the 2011 period. Contributing to this decrease were lower sales volume of $11.4 million and $0.6 million from unfavorable currency rates in Europe, partially offset by $2.3 million from higher customer pricing/mix. Total pounds of product sold in the fourth quarter of 2012 decreased by 3.6% compared to the fourth quarter of 2011.

Operating income for the quarter ended December 31, 2012 was $12.6 million compared to $11.5 million for the quarter ended December 31, 2011, an increase of $1.1 million, or 9.6%, due in part to the LIFO liquidation of $2.9 million in the 2012 period resulting from lower inventory levels at year-end which was partially offset by lower sales volume.

Net …read more
Source: FULL ARTICLE at DailyFinance

Walgreen Co. Reports Fiscal 2013 Second Quarter Results

By Business Wirevia The Motley Fool

Filed under:

Walgreen Co. Reports Fiscal 2013 Second Quarter Results

  • Company reports adjusted second quarter earnings per diluted share of 96 cents, compared with adjusted earnings per diluted share of 88 cents in year-ago quarter; GAAP earnings per diluted share of 79 cents compared with 78 cents in last year’s second quarter
  • Cash flow from operations reaches second-quarter record $1.2 billion
  • Alliance Boots and joint synergy program on track to deliver first-year targets
  • Walgreens and Alliance Boots form strategic, long-term relationship with AmerisourceBergen; includes 10-year comprehensive agreement for AmerisourceBergen to handle pharmaceutical distribution for Walgreens

DEERFIELD, Ill.–(BUSINESS WIRE)– Walgreen Co. (NYSE, NASDAQ: WAG) today announced earnings and sales results for the second quarter and first half of fiscal year 2013 ended Feb. 28.

Net earnings determined in accordance with generally accepted accounting principles (GAAP) for the fiscal 2013 second quarter were $756 million or 79 cents per diluted share, compared with $683 million or 78 cents per diluted share in the year-ago quarter. Last year’s results benefited from one extra day versus the current year because of leap year.

Adjusted fiscal 2013 second quarter net earnings were $915 million or 96 cents per diluted share, compared with adjusted net earnings of $767 million or 88 cents per diluted share in the year-ago quarter. This year’s adjusted second quarter results exclude the negative impacts of 12 cents per diluted share in acquisition related items, and 5 cents per diluted share from the quarter’s LIFO provision.

“We are pleased with the quarter’s results as we saw substantial strength in our pharmacy performance, leading to strong earnings growth,” said Walgreens President and CEO Greg Wasson. “With our Balanceā„¢ Rewards program now totaling more than 60 million enrollments, our preferred status with four national Medicare Part D plan sponsors and our very successful flu shot program this year, our customers are responding to our purpose to help them get, stay and live …read more
Source: FULL ARTICLE at DailyFinance